Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/170198
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Development of advanced biantibiotic loaded bone cement spacers for arthroplasty associated infections |
Autor: | Parra, Francisco CSIC ORCID ; González-Gómez, Álvaro CSIC ORCID; Fernández-Gutiérrez, Mar CSIC ORCID ; Parra, J.; García-García, J.; Azuara, G.; Torre, B. de la; Buján, J.; Ibarra, B.; Duocastella Codina, Luis; Molina-Crisol, M.; Vázquez-Lasa, Blanca CSIC ORCID; San Román, Julio CSIC | Palabras clave: | Daptomycin Linezolid Infection S. aureus. Acrylic bone cement spacers |
Fecha de publicación: | 2017 | Editor: | Elsevier | Citación: | International journal of pharmaceutics 522: 11-20 (2017) | Resumen: | The incidence increase of infections in patients with hip or knee implants with resistant pathogens (mainly some S. coagulase-negative and gram positive bacteria) demands advanced antibiotic loaded formulations. In this paper, we report the design of new biantibiotic acrylic bone cements for in situ delivery. They include a last generation antibiotic (daptomycin or linezolid) in combination with vancomycin and are performed based on a novel modification of the Palacos R acrylic bone cement, which is based on two components, a liquid (methyl methacrylate) and a solid (polymeric phase). Hence, the solid component of the experimental formulations include 45 wt% of microparticles of poly(D,L-lactic-co-glycolic) acid, 55 wt% of poly(methyl methacrylate) beads and supplements (10 wt-% each) of antibiotics. These formulations provide a selective and excellent control of the local release of antibiotics during a long time period (up to 2 months), avoiding systemic dissemination. The antimicrobial activity of the advanced spacers tested against S. aureus shows that single doses would be enough for the control of the infection. In vitro biocompatibility of cements on human osteoblasts is ensured. This paper is mainly focused on the preparation and characterization of cements and the studies of elution kinetics and bactericidal effects. Developed formulations are proposed as spacers for the treatment of infected arthroplasties, but also, they could be applied in other antibiotic devices to treat relevant bone-related infection diseases. | Versión del editor: | http://dx.doi.org/10.1016/j.ijpharm.2017.02.066 | URI: | http://hdl.handle.net/10261/170198 | DOI: | 10.1016/j.ijpharm.2017.02.066 | Identificadores: | doi: 10.1016/j.ijpharm.2017.02.066 issn: 0378-5173 e-issn: 1873-3476 |
Aparece en las colecciones: | (ICTP) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
24
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
18
checked on 23-feb-2024
Page view(s)
280
checked on 23-abr-2024
Download(s)
117
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.